Trial intelligence / Profile preview

Micuronium Chloride Dose for Laryngeal Mask Insertion in Short Surgeries

ChiCTR2500114392Phase 4Not yet recruiting

Sponsor
Weihai Municipal Hospital
Start
Dec 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of mivacurium (3 arms), sponsored by Weihai Municipal Hospital. Primary endpoints: Laryngeal mask insertion process, Conditions for insertion of laryngeal mask and 2 more. Planned start Dec 2025; status: not yet recruiting.

02

Drugs

mivacurium

Beyond the preview

Go deeper on ChiCTR2500114392.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2500114392.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call